diff options
| author | David A. Madore <david+git@madore.org> | 2020-04-22 00:58:07 +0200 |
|---|---|---|
| committer | David A. Madore <david+git@madore.org> | 2020-04-22 00:58:07 +0200 |
| commit | 4dc558b4310eaee625a09f4cacaa7f639c108a20 (patch) | |
| tree | 474b93450bddd6649fa353c122666ae7f150e9dd | |
| parent | d96b18ca65e96abc64cffa55f30f58aa8c376e24 (diff) | |
| download | covid19-4dc558b4310eaee625a09f4cacaa7f639c108a20.tar.gz covid19-4dc558b4310eaee625a09f4cacaa7f639c108a20.tar.bz2 covid19-4dc558b4310eaee625a09f4cacaa7f639c108a20.zip | |
Summary of the state of knowledge on immunity.
| -rw-r--r-- | covid19-links.md | 4 |
1 files changed, 4 insertions, 0 deletions
diff --git a/covid19-links.md b/covid19-links.md index 7cc89ad..a54519a 100644 --- a/covid19-links.md +++ b/covid19-links.md @@ -83,6 +83,10 @@ 5.7% of the population will have been infected by May 11. *\[Move this to the country-specific section?\]* +* [Persistence and efficiency of antibodies against SARS-CoV-2: the + state of current + knowledge](https://www.vidal.fr/actualites/24770/persistance_et_efficacite_des_anticorps_neutralisants_contre_le_sars_cov_2_etat_des_connaissances_et_lecons_des_autres_coronavirus_humains/) (2020-04-20 \[in French\]). + * [Effectiveness of convalescent plasma therapy in severe COVID-19 patients](https://www.pnas.org/content/early/2020/04/02/2004168117) (2020-04-06, PNAS) ⚔ [Twitter thread discussing |